Clinical outcomes of drug-eluting balloon for treatment of small coronary artery in patients with acute myocardial infarction.

医学 内科学 心肌梗塞 心脏病学 经皮冠状动脉介入治疗 传统PCI 血管成形术 狼牙棒 药物洗脱支架 冠状动脉疾病 心源性休克 血运重建 动脉 气球 急性冠脉综合征
作者
Qiang Tan,Qingsheng Wang,Hongmei Yang,Zhang Jing,Chen Ming
出处
期刊:Internal and Emergency Medicine [Springer Science+Business Media]
卷期号:16 (4): 913-918 被引量:1
标识
DOI:10.1007/s11739-020-02530-w
摘要

There were good clinical outcomes of drug-eluting balloon (DEB) use in de novo lesions and in-stent restenosis (ISR) lesions. However, few studies focused on DEB use in patients with acute myocardial infarction (AMI). The aim of this study was to retrospective evaluate the efficacy of DEB for patients of AMI with de novo small coronary artery disease. Between March 2016 and March 2018, patients of AMI with de novo small coronary artery (reference diameter 2.0–2.8 mm) and received percutaneous coronary intervention (PCI) were enrolled. 268 patients were divided into DEB group (PCI with further DEB, n = 56) and drug-eluting stent (DES) group (PCI with further DES, n = 212). The primary endpoint was major adverse cardiac events (MACE; all-cause death, non-fatal myocardial infarction, target lesion revascularization and target vessel revascularization) at 24 months. A subset of patients underwent angiographic follow-up. Clinical characteristics were balanced in the two groups. Mean reference vessel diameter was similar between the DEB and DES groups (2.64 ± 0.17 mm vs 2.65 ± 0.14 mm, P = 0.625). The 24-month MACE rates were 17.5% in DEB group and 16.4% in DES group (P = 0.853). Stent thrombosis was seen in three patients (1.46%) in DES group. There was no vessel thrombosis noted in the DEB group. Angiographic follow-up was performed in 35.71% of DEB group and 27.25% of DES group. Late lumen loss was similar between the two groups (DEB 0.14 ± 0.13 mm, DES 0.19 ± 0.12 mm, P = 0.442). DEB is a reasonable strategy for AMI with small coronary artery. Compared with DES, DEB is an alternative strategy which had similar 24-month clinical outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
勤恳数据线完成签到,获得积分10
刚刚
子夜歌发布了新的文献求助10
刚刚
cdercder的应助被rui采纳,获得20
刚刚
林海发布了新的文献求助10
刚刚
1秒前
现代念云完成签到,获得积分10
1秒前
友好的广缘完成签到,获得积分10
1秒前
1秒前
2秒前
HHHHHHHHHH完成签到,获得积分10
2秒前
4秒前
xixi发布了新的文献求助10
4秒前
充电宝的应助被huluhululu采纳,获得10
4秒前
67发布了新的文献求助10
4秒前
Della发布了新的文献求助20
5秒前
6秒前
碧绿的雪莲完成签到 ,获得积分10
7秒前
7秒前
坚强孤容发布了新的文献求助10
8秒前
9秒前
寒冷的如之完成签到 ,获得积分10
9秒前
albbxmy完成签到,获得积分10
9秒前
小陈完成签到,获得积分20
9秒前
盗梦师完成签到 ,获得积分10
9秒前
雪落弟弟完成签到,获得积分10
11秒前
吉吉国王发布了新的文献求助10
12秒前
12秒前
Lan完成签到 ,获得积分10
13秒前
美熙完成签到,获得积分10
14秒前
传奇3的应助被ycg采纳,获得10
15秒前
无极微光的应助被花藏影采纳,获得20
16秒前
晓倩完成签到,获得积分10
16秒前
贪玩以蓝完成签到,获得积分10
17秒前
NexusExplorer的应助被舒心雅蕊采纳,获得10
17秒前
言兼发布了新的文献求助10
18秒前
18秒前
YC完成签到,获得积分10
18秒前
19秒前
19秒前
shonn完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187006
求助须知:如何正确求助?哪些是违规求助? 9575262
关于积分的说明 21840460
捐赠科研通 7784748
什么是DOI,文献DOI怎么找? 3434903
关于科研通互助平台的介绍 2559301
邀请新用户注册赠送积分活动 2481765